Prof. Roger von Moos
Intense therapy in patients with locally advanced esophageal cancer beyond hope for surgical cure: a prospective, multicenter phase II trial of the Swiss Group for Clinical Cancer
Ruhstaller T, Köberle D, von Briel C, Lombriser N, Lohri A, Pederiva S, von Moos R, Thierstein S, Borner M, Schuller J, Ribi K, Templeton A, Popescu R. Intense therapy in patients with locally advanced esophageal cancer beyond hope for surgical cure: a prospective, multicenter phase II trial of the Swiss Group for Clinical Cancer. Onkologie 2010; 33:222-228.
Jan 1, 2010Intense therapy in patients with locally advanced esophageal cancer beyond hope for surgical cure: a prospective, multicenter phase II trial of the Swiss Group for Clinical Cancer
Jan 1, 2010Onkologie 2010; 33:222-228
Ruhstaller Thomas, Köberle Dieter, von Briel C, Lombriser N, Lohri A, Pederiva S, von Moos Roger, Thierstein S, Borner M, Schuller J C, Ribi K, Templeton Arnoud, Popescu R
Limited predictive value of FDG-PET for response assessment in the preoperative treatment of esophageal cancer: results of a prospective multi-center trial (SAKK 75/02)
Klaeser B, Ruhstaller T, von Moos R, Albrecht S, Caspar C, Pestalozzi B, Zünd M, Brauchli P, Cescato-Wenger C, Hany T, Balmer-Majno S, Widmer L, Köberle D, Schuller J, Nitzsche E, Lange J. Limited predictive value of FDG-PET for response assessment in the preoperative treatment of esophageal cancer: results of a prospective multi-center trial (SAKK 75/02). Onkologie 2009; 32:724-30.
Dec 1, 2009Limited predictive value of FDG-PET for response assessment in the preoperative treatment of esophageal cancer: results of a prospective multi-center trial (SAKK 75/02)
Dec 1, 2009Onkologie 2009; 32:724-30
Klaeser Bernd, Ruhstaller Thomas, von Moos Roger, Albrecht Susanne, Caspar Clemens, Pestalozzi Bernhard C, Zünd Michael, Brauchli Peter, Cescato-Wenger Corinne, Hany Thomas, Balmer-Majno Sabine, Widmer Lucas, Köberle Dieter, Schuller Jan C, Nitzsche Egbert, Lange Jochen
Temozolomide combined with bevacizumab in metastatic melanoma. A multicenter phase II trial (SAKK 50/07)
von Moos R, Goldinger S, Michielin O, Schuller J, Gillessen Sommer S, Schlaeppi M, Cathomas R, Ochsenbein A, Seifert B, Dummer R (2009). Temozolomide combined with bevacizumab in metastatic melanoma. A multicenter phase II trial (SAKK 50/07). Presented at: ECCO / ESMO, Berlin
Sep 22, 2009Temozolomide combined with bevacizumab in metastatic melanoma. A multicenter phase II trial (SAKK 50/07)
Sep 22, 2009ECCO / ESMO
von Moos Roger, Goldinger S., Michielin O., Schuller J.C., Gillessen Sommer Silke, Schlaeppi Marc, Cathomas R., Ochsenbein A., Seifert B., Dummer R.
Heated (37 degrees C) oxaliplatin infusion in combination with capecitabine for metastatic colorectal carcinoma: can it reduce neuropathy?
Cathomas R, Köberle D, Ruhstaller T, Mayer G, Räss A, Mey U, von Moos R. Heated (37 degrees C) oxaliplatin infusion in combination with capecitabine for metastatic colorectal carcinoma: can it reduce neuropathy?. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2009
Sep 12, 2009Heated (37 degrees C) oxaliplatin infusion in combination with capecitabine for metastatic colorectal carcinoma: can it reduce neuropathy?
Sep 12, 2009Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2009
Cathomas Richard, Köberle Dieter, Ruhstaller Thomas, Mayer Gisela, Räss Andrea, Mey Ulrich, von Moos Roger
Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation?
Ribi K, Pestalozzi B, Lombriser N, Borner M, von Moos R, Moosmann P, Hess V, Roth A, Honegger H, Schuller J, Köberle D, Ruhstaller T. Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation?. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2009; 17:1109-1116.
Feb 7, 2009Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation?
Feb 7, 2009Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2009; 17:1109-1116
Ribi Karin, Pestalozzi Bernhard, Lombriser Norbert, Borner Markus, von Moos Roger, Moosmann Peter, Hess Viviane, Roth Arnaud, Honegger Hanspeter, Schuller Jan C, Köberle Dieter, Ruhstaller Thomas
Breast cancer patients on endocrine therapy reveal more symptoms when self-reporting than in pivotal trials: an outcome research study
Ruhstaller T, Böhme C, Hess D, Hoefliger M, Mueller U, Köberle D, Spaeti B, Glaus A, Ribi K, Rufibach K, von Moos R, Thürlimann B. Breast cancer patients on endocrine therapy reveal more symptoms when self-reporting than in pivotal trials: an outcome research study. Oncology 2009; 76:142-8.
Jan 1, 2009Breast cancer patients on endocrine therapy reveal more symptoms when self-reporting than in pivotal trials: an outcome research study
Jan 1, 2009Oncology 2009; 76:142-8
Ruhstaller Thomas, Böhme Christel, Hess Dagmar, Hoefliger Markus, Mueller Urs, Köberle Dieter, Spaeti Bruno, Glaus Agnes, Ribi Karin, Rufibach Kaspar, von Moos Roger, Thürlimann Beat
Fatal herpes simplex virus hepatitis in a patient with esophageal cancer under radiochemotherapy
Grimm B, Padberg B, Ruhstaller T, Fleisch F, von Moos R. Fatal herpes simplex virus hepatitis in a patient with esophageal cancer under radiochemotherapy. Onkologie 2008; 31:620-2.
Nov 1, 2008Fatal herpes simplex virus hepatitis in a patient with esophageal cancer under radiochemotherapy
Nov 1, 2008Onkologie 2008; 31:620-2
Grimm Birgit, Padberg Barbara, Ruhstaller Thomas, Fleisch Felix, von Moos Roger
Metastatic bone pain: treatment options with an emphasis on bisphosphonates
von Moos R, Strasser F, Gillessen Sommer S, Zaugg K. Metastatic bone pain: treatment options with an emphasis on bisphosphonates. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2008; 16:1105-15.
Oct 1, 2008Metastatic bone pain: treatment options with an emphasis on bisphosphonates
Oct 1, 2008Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2008; 16:1105-15
von Moos Roger, Strasser Florian, Gillessen Sommer Silke, Zaugg Kathrin
Pegylated liposomal doxorubicin-associated hand-foot syndrome: recommendations of an international panel of experts
von Moos R, Lademann J, Lacouture M, Dummer R, Lorusso D, Scotte F, Sehouli J, Harrold K, Rayson D, Aapro M, Thürlimann B, Hauschild A. Pegylated liposomal doxorubicin-associated hand-foot syndrome: recommendations of an international panel of experts. EJO 2008; 44:781-90.
Apr 1, 2008Pegylated liposomal doxorubicin-associated hand-foot syndrome: recommendations of an international panel of experts
Apr 1, 2008EJO 2008; 44:781-90
von Moos Roger, Lademann Jürgen, Lacouture Mario E, Dummer Reinhard, Lorusso Domenica, Scotte Florian, Sehouli Jalid, Harrold Karen, Rayson Daniel, Aapro Matti, Thürlimann Beat, Hauschild Axel
Malignes Melanom
Schlaeppi M, Anliker M, von Moos R. Malignes Melanom. TMJ 2008; 2:17-19.
Jan 1, 2008Malignes Melanom
Jan 1, 2008TMJ 2008; 2:17-19
Schlaeppi Marc, Anliker Mark, von Moos Roger
Is surgery still part of local therapy in patients with locally advanced esophageal carcinoma?
Ruhstaller T, Thürlimann B, Köberle D, von Moos R. Is surgery still part of local therapy in patients with locally advanced esophageal carcinoma?. JCO 2007; 25:4025-6; author reply 4026-7.
Sep 1, 2007Is surgery still part of local therapy in patients with locally advanced esophageal carcinoma?
Sep 1, 2007JCO 2007; 25:4025-6; author reply 4026-7
Ruhstaller Thomas, Thürlimann Beat, Köberle Dieter, von Moos Roger
Pegylated liposomal doxorubicin (caelyx) in metastatic breast cancer: a community-based observation study
Salzberg M, Thürlimann B, Hasler U, Delmore G, von Rohr A, Thurlimann A, Ruhstaller T, Stopatschinskaja S, von Moos R. Pegylated liposomal doxorubicin (caelyx) in metastatic breast cancer: a community-based observation study. Oncology 2007; 72:147-51.
Jan 1, 2007Pegylated liposomal doxorubicin (caelyx) in metastatic breast cancer: a community-based observation study
Jan 1, 2007Oncology 2007; 72:147-51
Salzberg Marc, Thürlimann Beat, Hasler Ursula, Delmore Geoffrey, von Rohr Albert, Thurlimann Annatina, Ruhstaller Thomas, Stopatschinskaja Shanna, von Moos Roger
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
Waeckerle-Men Y, Groettrup M, Ludewig B, Cerny T, Ackermann D, Schmid H, Böhme C, von Moos R, Fopp M, Uetz-von Allmen E, Gillessen Sommer S. Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma. Cancer immunology, immunotherapy : CII 2006; 55:1524-33.
Dec 1, 2006Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
Dec 1, 2006Cancer immunology, immunotherapy : CII 2006; 55:1524-33
Waeckerle-Men Ying, Groettrup Marcus, Ludewig Burkhard, Cerny Thomas, Ackermann Daniel, Schmid Hans-Peter, Böhme Christel, von Moos Roger, Fopp Markus, Uetz-von Allmen Edith, Gillessen Sommer Silke
Successful treatment of acute disseminated intravascular coagulation in a patient with metastatic melanoma
Schlaeppi M, Korte W, von Moos R, Cerny T, Gillessen Sommer S. Successful treatment of acute disseminated intravascular coagulation in a patient with metastatic melanoma. Onkologie 2006; 29:531-3.
Nov 1, 2006Successful treatment of acute disseminated intravascular coagulation in a patient with metastatic melanoma
Nov 1, 2006Onkologie 2006; 29:531-3
Schlaeppi Marc, Korte Wolfgang, von Moos Roger, Cerny Thomas, Gillessen Sommer Silke
CASE 3. Red eye in Sjogren's syndrome due to underlying mucosa-associated lymphoid tissue lymphoma
von Moos R, Ruhstaller T, Fretz C. CASE 3. Red eye in Sjogren's syndrome due to underlying mucosa-associated lymphoid tissue lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006; 24:1011-3.
Feb 20, 2006CASE 3. Red eye in Sjogren's syndrome due to underlying mucosa-associated lymphoid tissue lymphoma
Feb 20, 2006Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006; 24:1011-3
von Moos Roger, Ruhstaller Thomas, Fretz Christian
Dendritic cells generated from patients with androgen-independent prostate cancer are not impaired in migration and T-cell stimulation
Waeckerle-Men Y, Allmen E, von Moos R, Classon B, Scandella E, Schmid H, Ludewig B, Groettrup M, Gillessen Sommer S. Dendritic cells generated from patients with androgen-independent prostate cancer are not impaired in migration and T-cell stimulation. The Prostate 2005; 64:323-31.
Sep 1, 2005Dendritic cells generated from patients with androgen-independent prostate cancer are not impaired in migration and T-cell stimulation
Sep 1, 2005The Prostate 2005; 64:323-31
Waeckerle-Men Ying, Allmen Edith Uetz-von, von Moos Roger, Classon Brendan J, Scandella Elke, Schmid Hans-Peter, Ludewig Burkhard, Groettrup Marcus, Gillessen Sommer Silke
Current concepts of treatment strategies in advanced or recurrent ovarian cancer
Salzberg M, Thürlimann B, Bonnefois H, Fink D, Rochlitz C, von Moos R, Senn H. Current concepts of treatment strategies in advanced or recurrent ovarian cancer. Oncology 2005; 68:293-8.
Jan 1, 2005Current concepts of treatment strategies in advanced or recurrent ovarian cancer
Jan 1, 2005Oncology 2005; 68:293-8
Salzberg Marc, Thürlimann Beat, Bonnefois Hervé, Fink Daniel, Rochlitz Christoph, von Moos Roger, Senn Hansjorg
Thalidomide: from tragedy to promise
von Moos R, Stolz R, Cerny T, Gillessen Sommer S. Thalidomide: from tragedy to promise. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2003; 133:77-87.
Feb 8, 2003Thalidomide: from tragedy to promise
Feb 8, 2003Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2003; 133:77-87
von Moos Roger, Stolz Rahel, Cerny Thomas, Gillessen Sommer Silke